X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Our study is a prospective, randomized phase II clinical trial, to compare the efficacy and
safety profiles of single X versus placebo as adjuvant chemotherapy regimens for elder breast
cancer patients.